| 注册
首页|期刊导航|中国神经再生研究(英文版)|Association of plasminogen activator inhibitor-1 4G/5G promoter polymorphism with recurrent cerebral infarction in China's North Jiangsu Province

Association of plasminogen activator inhibitor-1 4G/5G promoter polymorphism with recurrent cerebral infarction in China's North Jiangsu Province

Deqin Geng Jijun Zhu Guofang Chen Xianbi Tang Qiaoyun Yang Jizhen Li Fumin Liu

中国神经再生研究(英文版)2008,Vol.3Issue(7):791-794,4.
中国神经再生研究(英文版)2008,Vol.3Issue(7):791-794,4.

Association of plasminogen activator inhibitor-1 4G/5G promoter polymorphism with recurrent cerebral infarction in China's North Jiangsu Province

Association of plasminogen activator inhibitor-1 4G/5G promoter polymorphism with recurrent cerebral infarction in China's North Jiangsu Province

Deqin Geng 1Jijun Zhu 1Guofang Chen 2Xianbi Tang 1Qiaoyun Yang 1Jizhen Li 1Fumin Liu3

作者信息

  • 1. Department of Neurology,Affiliated Hospital of Xuzhou Medical College,Xuzhou 221002,Jiangsu Province,China
  • 2. Department of Neurology,Xuzhou Central Hospital Xuzhou 221001,Jiangsu Province,China
  • 3. Central Laboratory,Affiliated Hospital of Xuzhou Medical College Xuzhou 221002,Jiangsu Province,China
  • 折叠

摘要

Abstract

BACKGROUND:Many international studies have shown that plasminogen activator inhibitor-l(PAI-1)4G/5G promoter polymorphism does not increase the risk for cerebral infarction.OBJECTIVE:Using PCR methodology and agarose electrophoresis to detect PAl-1 4G/5G promoter polymorphism in patients with recurrent cerebral infarction in the North Jiangsu Province of China,and to compare results with healthy subjects and patients with first-occurrence cerebral infarction in the same region.DESIGN,TIME AND SETTING:Non-randomized,concurrent,control trial.A total of 122 cerebral infarction patients were admitted to Xuzhou Medical College Hospital's Department of Neurology and Xuzhou Central Hospital's Department of Neurology between July 2003 and August 2006.PARTlCIPANTS:The patients consisted of 63 males and 59 females,aged(62±10)years.They were divided into first-occurrence(n=58)and recurrence(n=64)groups.In addition,50 healthy subjects that underwent physical examination in the outpatient department,including 26 males and 24 females,aged (60±12)years,were selected as controls.METHODS AND MAIN OUTCOME MEASURES:PAI-1 4G/5G pmmoter polymorphism was detected and analyzed using PCR methodology and agarose electrophoresis.RESULTS:Significant differences were determined in terms of genotypic frequency and allele frequency of PAI-1 4G/5G promoter polymorphism,in patients with first-occurrence or recurrent cerebral infarction,when compared with healthy subjects(P<0.05).There was,however,no significant differenco between the first-occurrence and recurrence groups(P>0.05).CONCLUSION:PAI=1 4G/5G promoter polymorphism is genetic risk factor for cerebral infarction in China.However,it may be associated with recurrence of cerebral infarction in padents from the North Jiangsu Province of China.

关键词

plasminogen activator inhibitor-1/gene/polymorphism/recurrent cerebral infarction

Key words

plasminogen activator inhibitor-1/gene/polymorphism/recurrent cerebral infarction

分类

医药卫生

引用本文复制引用

Deqin Geng,Jijun Zhu,Guofang Chen,Xianbi Tang,Qiaoyun Yang,Jizhen Li,Fumin Liu..Association of plasminogen activator inhibitor-1 4G/5G promoter polymorphism with recurrent cerebral infarction in China's North Jiangsu Province[J].中国神经再生研究(英文版),2008,3(7):791-794,4.

基金项目

the Xuzhou Social Development Foundation of Jiangsu Province.No.2006046 ()

中国神经再生研究(英文版)

OACSCDSCI

1673-5374

访问量0
|
下载量0
段落导航相关论文